id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-4225-0133,FDA,FDA-2023-N-4225,Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal,Proposed Rule,Withdrawal,2025-11-28T05:00:00Z,2025,11,2025-11-28T05:00:00Z,,2025-11-28T19:47:58Z,2025-21407,0,0,09000064b90a1ed0
FDA-2023-N-4225-0099,FDA,FDA-2023-N-4225,Request for Extension from U.S. Chamber of Commerce,Other,Request for Extension,2025-03-21T04:00:00Z,2025,3,2025-03-21T04:00:00Z,,2025-03-21T13:56:27Z,,0,0,0900006486a08a9d
FDA-2023-N-4225-0100,FDA,FDA-2023-N-4225,Request for Extension from Essential Minerals Association,Other,Request for Extension,2025-03-21T04:00:00Z,2025,3,2025-03-21T04:00:00Z,,2025-03-21T13:58:09Z,,0,0,0900006486a0bb00
FDA-2023-N-4225-0083,FDA,FDA-2023-N-4225,Memorandum re Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products (Proposed Rule),Other,Memorandum,2025-01-23T05:00:00Z,2025,1,2025-01-23T05:00:00Z,,2025-01-23T20:44:28Z,,0,0,09000064868f192c
FDA-2023-N-4225-0084,FDA,FDA-2023-N-4225,TAB A - Asbestos in Talc NPRM as Submitted to OMB,Supporting & Related Material,Background Material,2025-01-23T05:00:00Z,2025,1,,,2025-01-23T20:46:08Z,,0,0,09000064868f10ef
FDA-2023-N-4225-0087,FDA,FDA-2023-N-4225,TAB B - Asbestos in Talc PRIA Track Changes,Supporting & Related Material,Background Material,2025-01-23T05:00:00Z,2025,1,,,2025-01-23T20:46:28Z,,0,0,09000064868f10f2
FDA-2023-N-4225-0088,FDA,FDA-2023-N-4225,TAB C - Asbestos in Talc NPRM as Cleared by OMB,Supporting & Related Material,Background Material,2025-01-23T05:00:00Z,2025,1,,,2025-01-23T20:46:34Z,,0,0,09000064868f10f3
FDA-2023-N-4225-0086,FDA,FDA-2023-N-4225,TAB B - Asbestos in Talc NPRM Track Changes,Supporting & Related Material,Background Material,2025-01-23T05:00:00Z,2025,1,,,2025-01-23T20:46:23Z,,0,0,09000064868f10f1
FDA-2023-N-4225-0085,FDA,FDA-2023-N-4225,TAB A - Asbestos in Talc PRIA as Submitted to OMB,Supporting & Related Material,Background Material,2025-01-23T05:00:00Z,2025,1,,,2025-01-23T20:46:17Z,,0,0,09000064868f10f0
FDA-2023-N-4225-0089,FDA,FDA-2023-N-4225,TAB C - Asbestos in Talc PRIA as Cleared by OMB,Supporting & Related Material,Background Material,2025-01-23T05:00:00Z,2025,1,,,2025-01-23T20:46:41Z,,0,0,09000064868f10f4